#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal atresia Splenic marginal zone lymphoma Vulval cancer recurrent Krabbe's disease Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Chronic cutaneous lupus erythematosus Heritable pulmonary arterial hypertension Systemic lupus erythematosus Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Cold type haemolytic anaemia Indolent systemic mastocytosis Antiphospholipid antibodies Ventricular fibrillation Retinitis pigmentosa Fibrosarcoma metastatic More trials…

    Learn about Rare Diseases

    Sarcoidosis Mucopolysaccharidosis III – Treatment Mantle cell lymphoma – Diagnostics IgA nephropathy – Life with Disease Myelodysplastic syndrome Indolent systemic mastocytosis – Trials in Disease Marfan’s syndrome – Treatment Fragile X syndrome – Treatment Lymphangiosarcoma Hepatoblastoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tazobactam Sodium LTX-002 SODIUM Apremilast Human Immunoglobulin G FG001 Colchicine Methyl Aminolevulinate Azd3470 AZD0022 SURVODUTIDE Glucose Monohydrate Ph. Eur. Afimetoran Besilate Dihydrate Danazol VMX-C001 Tiratricol Lamotrigine Izokibep Livmoniplimab Tak-280 Sparsentan More therapies…

    Learn about Your Condition

    Psoriatic arthropathy Postprandial hypoglycaemia Astrocytoma malignant Bladder cancer stage III Kearns-Sayre syndrome Neonatal anoxia Pseudomyxoma peritonei Cervix carcinoma Myocarditis Noninfective chorioretinitis Angina pectoris Hypersomnia Cerebral amyloid angiopathy Breast cancer metastatic Injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Use of Epinephrine for Newborns with Cardiac Arrest at Birth

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Epinephrine
    France

  • Study on the Effects of Acetylcarnitine Hydrochloride in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    4 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • ACETYLCARNITINE HYDROCHLORIDE
    Italy

  • Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Rotigotine
    France

  • Study on Fluorescence-Guided Surgery Using cRGD-ZW800-1 for Patients with Laryngeal and Hypopharyngeal Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the hypopharynx
    Investigated Drugs:
    • Crgd-Zw800-1
    The Netherlands

  • Study on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    Belgium Italy The Netherlands Portugal Spain

  • Study on the Effect of Human Serum Albumin in Critically Ill Patients with Septic Shock at High Risk of Acute Kidney Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    • Acute kidney injury
    Investigated Drugs:
    • Human Serum Albumin
    Spain
Previous Page
1 … 277 278 279 280 281 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!